EPISODE · Jun 19, 2019 · 6 MIN
Adding Ribociclib to Endocrine Therapy Improves OS in Young Patients With Advanced Breast Cancer
from Oncology Learning Network · host HMP Global
Sara A. Hurvitz, MD, University of California-Los Angeles Jonsson Comprehensive Cancer Center, discusses the background, findings, and clinical significance of the MONALEESA 7 trial, the findings of which were presented at the 2019 ASCO Annual Meeting.
Embed this episode
Ready to play
Adding Ribociclib to Endocrine Therapy Improves OS in Young Patients With Advanced Breast Cancer
0:00
6:20
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Oncology Learning Network?
This episode is 6 minutes long.
When was this Oncology Learning Network episode published?
This episode was published on June 19, 2019.
Can I download this Oncology Learning Network episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!